Bio

Joel H. Dobbs is the CEO and President of The Compass Talent Management Group LLC (CTMG), a consulting firm that assists organizations with the identification and development of key talent and with designing organizational strategies and structures to maximize their ability to compete in the business worlds of today and tomorrow. CTMG focuses in four areas that are critical for business success.  These are:  Developing mission, vision and values; Building effective leaders through e...

Joel H. Dobbs is the CEO and President of The Compass Talent Management Group LLC (CTMG), a consulting firm that assists organizations with the identification and development of key talent and with designing organizational strategies and structures to maximize their ability to compete in the business worlds of today and tomorrow. CTMG focuses in four areas that are critical for business success.  These are:  Developing mission, vision and values; Building effective leaders through executive coaching; Maximizing organizational effectiveness; and, Transformational change leadership.

Most recently Joel was Vice President, Information Technology at Eisai Inc., the US unit of Eisai, a $6B global pharmaceutical company headquartered in Tokyo Japan.  Prior to this role he served as VP of Information Technology, Data Management and Business Re-Engineering at Eisai Medical Research, the global clinical development arm of Eisai.  He spent two years as Executive in Residence and Program Director of the Pharmaceutical Management Program at Stevens Institute of Technology and as a consultant to numerous pharmaceutical, biotechnology and software companies.  He also served as Vice-President, Research Information Services and Global IT Strategy and Compliance for Schering-Plough Corporation.  In this capacity, he was responsible for all information technology for the Schering Plough Research Institute as well as for strategy and IT regulatory compliance globally.  Before joining Schering-Plough Joel spent 12 years with Glaxo Inc. in various management and executive positions in regulatory affairs, medical services and information services.  He also spent one year with Glaxo Wellcome as Worldwide Director, Information Management and Analysis and has also served as a professor of pharmacy at Samford University and as Vice President and a Managing Partner for Pharmacy Specialties, Inc., a pharmacy management-consulting firm.

Joel is the author of numerous scientific and technical publications, including chapters in five books, and is a frequent speaker at industry-related seminars and conferences.  He served on the Compaq Computer Corporation Pharmaceutical Advisory Board, the Digital Equipment Corporation Pharmaceutical Advisory Board, the PhRMA / FDA Information Management Working Group, the PhRMA CIO Forum, the PMA Information Management Steering Committee, the Documentum Advisory Council, and the PMA Safety Surveillance Committee.  He represented the pharmaceutical industry on the steering committee for the Industry Coalition on Part 11 which worked with the FDA to successfully revise the guidance for compliance with this regulation.  

Joel is past chair of PhRMA’s Information Management Policy and Coordinating Committee and past chair of the Pharmaceutical Research Information Executive Forum.  He serves on the Boards of several non-profit organizations and has previously served on the editorial boards of the Annals of Pharmacotherapy, the Drug Information Journal, and Applied Clinical Trials.

Joel received a BS in pharmacy from Samford University, a Master of Public Health from the University of Alabama in Birmingham, and a doctorate in pharmacy from the University of Tennessee.  He has completed executive programs at Duke University’s Fuqua School of Business and MIT. He served as a consultant to numerous organizations including some of the world’s largest software companies and several small to midsize software, pharmaceutical and biotechnology companies and is a member of the board of directors of New Century Pharmaceuticals.